ANNA MILLER: Open Payments
NPI 1184322281 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 13 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $331 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Genmab U.S., Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Geron Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: KEYTRUDA, MONJUVI, GIVLAARI, INJECTAFER, Epkinly, NINLARO, KISQALI, RYTELO.
Industry payments across KY — which companies pay providers there.
